References
- 1. Altman DG, Machin D, Bryant TN, Gardner RJ. Statistics with confidence. 2nd ed. Bristol: BMJ Books; 2000
- 2. Bhargava R, Beriwal S, Dabbs DJ, Ozbek U, So-ron A, Johnson RR, Brafsky AM, Lembersky BC, Ahrendt GM. Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy: a single institutional experience with 359 cases // Cancer, 2010; 116:1431 – 1439
- 3. Coons SW, Johnson PC. Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index // J Neuropathol Exp Neurol, 1993; 52:609 – 618
- 4. Dalrymple SJ, Parisi JE, Roche PC, Ziesmer SC, Scheithauer BW, Kelly PJ. Changes in proliferating cell nuclear antigen expression in glioblastoma multiforme cells along a stereotactic biopsy trajec-tory // Neurosurgery, 1994; 35:1036 – 1045
- 5. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. Astrocytic tumors // Bosman FT, Jaffe ES, Lakhani RS, Ohgaki H. WHO classification of tumours of the central nervous system. 3rd edition. Lyon: IARC, 2007; 13 - 52
- 6. Milinkovic V, Bankovic J, Rakic M, Milosevic N, Stankovic T, Jokovic M, Milosevic Z, Skender-Gazibara M, Podolski-Renic A, Pesic M, Ruzdijic S, Tanic N. Genomic instability and p53 alterations in patients with malignant glioma // Exp Mol Pathol, 2012; 93:200 - 206
- 7. Ng K, Kim R, Kesari S, Carter B, Chen CC. Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights // J Neurooncol, 2012; 107:1 - 12
- 8. Nowell PC. The clonal evolution of tumor cell populations // Science, 1976; 194:23 - 28
- 9. Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma // Am J Pathol, 2007; 170:1445 - 1453
- 10. Ren ZP, Olofsson T, Qu M, Hesselager G, Soussi T, Kalimo H, Smits A, Nistér M. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors // J Neuropathol Exp Neurol, 2007; 66:944 - 954
- 11. Soussi T, Lozano G. p53 mutation heterogeneity in cancer // Biochem Biophys Res Commun, 2005; 331:834 - 842
- 12. Torp SH. Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies // Clin Neuropathol, 2002; 21:252 - 257